Lee, Richard E.
- St. Jude Children's Research Hospital · Pharmacology (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #10,861
- Rising Star
- Sustained Excellence
- R01 Holder
- Long-Funded
- Mentor
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$953.6K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#10,861
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Lee, Richard E. as a PI. Multi-PI records show the full award amount for context.
- 5R01AI157312-04R01Contact PISpectinomycin analogs for NTM infectionsSt. Jude Children's Research Hospital · Pharmacology (topic-inferred)$784.2Kaward amount
- 5T32AI106700-08T32Contact PITraining in the Design and Development of Infectious Disease TherapeuticsSt. Jude Children's Research Hospital · Pharmacology (topic-inferred)$169.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Lee, Richard E. as a PI.
FY2023 award administered by St. Jude Children's Research Hospital (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardSt. Jude Children's Research Hospital
- 2009$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #6186
- 2010$2M Cumulative Funding
- 2010Entered Top 25% NationallyRanked #3280
- 2011$5M Cumulative Funding
- 2013R01 Grant Holder
- 2014$10M Cumulative Funding